These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
766 related articles for article (PubMed ID: 29441009)
1. Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications. Uddin MS; Stachowiak A; Mamun AA; Tzvetkov NT; Takeda S; Atanasov AG; Bergantin LB; Abdel-Daim MM; Stankiewicz AM Front Aging Neurosci; 2018; 10():04. PubMed ID: 29441009 [TBL] [Abstract][Full Text] [Related]
2. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis. Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531 [TBL] [Abstract][Full Text] [Related]
3. Trilateral association of autophagy, mTOR and Alzheimer's disease: Potential pathway in the development for Alzheimer's disease therapy. Subramanian A; Tamilanban T; Alsayari A; Ramachawolran G; Wong LS; Sekar M; Gan SH; Subramaniyan V; Chinni SV; Izzati Mat Rani NN; Suryadevara N; Wahab S Front Pharmacol; 2022; 13():1094351. PubMed ID: 36618946 [TBL] [Abstract][Full Text] [Related]
4. Autophagy in Alzheimer's disease pathogenesis: Therapeutic potential and future perspectives. Zhang Z; Yang X; Song YQ; Tu J Ageing Res Rev; 2021 Dec; 72():101464. PubMed ID: 34551326 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles. Deng Z; Dong Y; Zhou X; Lu JH; Yue Z Acta Pharm Sin B; 2022 Apr; 12(4):1688-1706. PubMed ID: 35847516 [TBL] [Abstract][Full Text] [Related]
7. The Implications of Autophagy in Alzheimer's Disease. Hamano T; Hayashi K; Shirafuji N; Nakamoto Y Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076 [TBL] [Abstract][Full Text] [Related]
8. Autophagy Modulation in Aggresome Formation: Emerging Implications and Treatments of Alzheimer's Disease. Rahman MA; Rahman MDH; Mamun-Or-Rashid ANM; Hwang H; Chung S; Kim B; Rhim H Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625764 [TBL] [Abstract][Full Text] [Related]
10. β-Asarone Inhibits Amyloid-β by Promoting Autophagy in a Cell Model of Alzheimer's Disease. Wang N; Wang H; Li L; Li Y; Zhang R Front Pharmacol; 2019; 10():1529. PubMed ID: 32009952 [TBL] [Abstract][Full Text] [Related]
11. Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential. Zhang W; Xu C; Sun J; Shen HM; Wang J; Yang C Acta Pharm Sin B; 2022 Mar; 12(3):1019-1040. PubMed ID: 35530153 [TBL] [Abstract][Full Text] [Related]
12. Targeting Autophagy for the Treatment of Alzheimer's Disease: Challenges and Opportunities. Liu J; Li L Front Mol Neurosci; 2019; 12():203. PubMed ID: 31507373 [TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease? Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941 [TBL] [Abstract][Full Text] [Related]
14. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome. Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971 [TBL] [Abstract][Full Text] [Related]
15. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
16. Rapamycin, Autophagy, and Alzheimer's Disease. Cai Z; Yan LJ J Biochem Pharmacol Res; 2013 Jun; 1(2):84-90. PubMed ID: 23826514 [TBL] [Abstract][Full Text] [Related]
17. [Pathological changes induced by amyloid-β in Alzheimer's disease]. Takata K; Kitamura Y; Taniguchi T Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607 [TBL] [Abstract][Full Text] [Related]
18. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease. Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671 [TBL] [Abstract][Full Text] [Related]
19. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease. Reddy PH; Oliver DM Cells; 2019 May; 8(5):. PubMed ID: 31121890 [TBL] [Abstract][Full Text] [Related]
20. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease. Takahashi RH; Nagao T; Gouras GK Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]